Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
Equity - Leveraged / Inverse
Sponsor
Direxion Shares
Fund Family
Index
S&P Biotechnology Select Industry Index
Index Weighting
Active/Passive
Expense
0.96%
Inverse/Leveraged
IPO
May 28, 2015
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-4.26%
SMA50
-15.92%
SMA200
5.01%
Return% 1Y
105.96%
Return% 3Y
55.01%
Return% 5Y
-25.87%
Return% 10Y
Return% SI
Flows% 1M
22.86%
Flows% 3M
19.50%
Flows% YTD
-37.37%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
174
AUM
642.72M
NAV/sh
52W High
341.93 -34.17%
52W Low
108.90 106.70%
Volatility
9.37% 9.01%
ATR (14)
19.72
RSI (14)
45.01
Beta
2.53
Rel Volume
0.11
Avg Volume
397.84K
Volume
2,095
Perf Week
0.97%
Perf Month
-11.07%
Perf Quarter
-8.35%
Perf Half Y
17.45%
Perf YTD
41.23%
Perf Year
99.01%
Perf 3Y
297.70%
Perf 5Y
-78.71%
Perf 10Y
-67.86%
Prev Close
234.18
Price
225.10
Change %
-3.88%
Direxion Daily S&P Biotech Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.